In this issue

Issue 40 • June 2021

The European Union’s new Medical Device Regulation (MDR) has finally come into force, with all medical devices now required to adhere to a new set of rules and requirements before they can be sold or imported into the region.

While the MDR has been a long time – almost ten years – in the making, that doesn’t mean that device manufacturers will be fully prepared for how the transition may change their operations. As the new rules expand the definition of a medical device, software developers may find that their product now falls under the scope of MDR.

To find out more, we speak to international law firm Morrison & Foerster to discuss the changes coming into play for medical device software as the MDR is rolled out, from intended use and risk classification to the complexities of unique device identification.

Elsewhere, we get to grips with the next generation of medical wearables, find out how an AI-powered healthcare marketplace is helping the NHS to secure PPE supplies and examine the ethical issues surrounding the use of mechanical wombs to artificially gestate human embryos.

For all this, plus the latest insight and analysis from GlobalData, read on.

Eloise Mclennan, editor

Go to article: Home | What’s next for wearables?Go to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: BriefingGo to article: Industry newsGo to article: Covid-19 executive briefing by GlobalDataGo to article: The medical industry briefingGo to article: Repsol Company Insight Go to article: Repsol Go to article: Lenzing Plastics Company InsightGo to article: Lenzing PlasticsGo to article: device25Go to article: CommentGo to article: IVD companies seek M&As to avoid Covid cliffGo to article: The CGM-led diabetes market revolution post-Covid-19 outbreakGo to article: Novel solutions to tackle backlog of delayed proceduresGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: Duke Empirical Company Insight Go to article: Duke EmpiricalGo to article: In DepthGo to article: How will Europe’s new device regulations affect medical software?Go to article: The next phase for medical wearablesGo to article: How to future-proof the NHS supply chainGo to article: IUB Ballerine: an ergonomic approach to non-hormonal contraceptionGo to article: Creating connections with Within3Go to article: A womb with a view: the ethical dilemma of ectogenesisGo to article: Gee PlusGo to article: ElectroCraft Company InsightGo to article: ElectroCraftGo to article: GS SwissGo to article: In DataGo to article: Deals analysisGo to article: The medical industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: CoherentGo to article: On Line ControlsGo to article: Biesterfeld Go to article: EventsGo to article: Next Issue